On this well-defined genetic background of a core binding factor (CBF) leukemia with good prognosis, we analyzed gene expression in an AML cohort positive for inversion inv(16) or CBFB-MYH11 (cohort 1), which is frequently associated with oncogenic RAS mutations [5,19]. This evidence concerns the gene CBFB and acute myeloid leukemia.